Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-49.35%
End price
14.12.24
€0.82
Summary
This prediction ended on 14.12.24 with a price of €0.82. The BUY prediction by BiotechBee for Ocugen Inc. performed very badly with a performance of -49.35%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocugen Inc. | 11.306% | 11.306% | 43.478% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year